Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis. - Wikidata - awgldk - TriplyDB

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

http://www.wikidata.org/entity/Q39471229

about

The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Parasitic infections in travelers and immigrants: part I protozoa.Nutritional status in patients with cutaneous leishmaniasis and a study of the effects of zinc supplementation together with antimony treatment.Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide An overview on Leishmania vaccines: A narrative review article.Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials.Intralesional Pentamidine: A Novel Therapy for Single Lesions of Bolivian Cutaneous Leishmaniasis Clinical and epidemiologic profile of cutaneous leishmaniasis in Colombian children: considerations for local treatment.Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.Parasitic diseases in travelers: a focus on therapy.Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.Travelers with cutaneous leishmaniasis cured without systemic therapy.Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment.Intralesional Infiltration with Meglumine Antimoniate for the Treatment of Leishmaniasis Recidiva Cutis in Ecuador.Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.

P2860

Q26764752-63927312-DE1E-489F-B624-83C5378493A8 Q30275257-F248A0F5-19FB-4F62-865C-0B70A7AB69E5 Q30884858-E521F637-9BA4-4227-9937-B8566825B2F1 Q34474454-D38047F8-F7B5-45CD-BE69-F6BA87298A8C Q35160905-80BA0661-2A49-42E0-8C3A-20039F7C459B Q35517074-0EED7F24-6B9E-48F7-88CD-72996F715F53 Q36085124-D37CFAC6-B144-40AF-A62C-4FBFEC02748A Q36776108-2449FFFB-6EC3-4A81-8615-CA3E8B96F2EA Q37089640-2532560B-4D22-4C49-90A1-28824951CC73 Q37167729-01832BFD-7DC3-4C9F-8303-F5B6906D3287 Q38156421-92A155DF-4C76-48D6-8C77-BDCD54C6110D Q38192001-558F3FF9-DBAF-4F11-8229-ECBE9D561A7B Q38511211-ABE498E1-123F-4EDF-87A6-D437BBCF69C0 Q41677439-B2086BC4-FD51-4D2D-9AE4-EEF2D52E2FF4 Q45802306-85CA004C-AF73-4F0B-B9E4-6B36507A52E3 Q47118269-5301EE9B-3608-4DFF-89D2-092A0015ED52 Q49398553-99672BAE-962A-4069-8FFD-A2B7F0F698FF Q50088456-63BC7254-7D27-4314-8C7C-943A7C9C1F43 Q55398190-95DEC772-D553-4533-AA68-5F6D3A4429A2

P2860

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

http://www.wikidata.org/entity/Q39471229

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

@en

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

@nl

type

label

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

@en

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

@nl

prefLabel

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

@en

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

@nl

P1433

Q39471229-555D5C0A-7819-4653-BEA6-340EC925238F

P1476

Q39471229-56A9E9FA-3F5C-4750-A1D6-2BF1743A7684

P2093

Q39471229-0CAE418A-D967-49A5-9B88-C7BE00AF6E75

Q39471229-1342163A-C895-4C2F-866B-F10BB2F2CF06

Q39471229-26CAE4CF-576F-4F19-A9C7-EEADBBF5AC11

Q39471229-3AF6BFCA-1BB4-4376-A107-09DDD07EC96D

Q39471229-5CA06D06-5DBF-4C3A-A049-ACD66EDD4E50

Q39471229-5EEF369C-BB2B-4BD6-87F9-B7E712678A96

Q39471229-8E74B9C0-D0FB-45D1-969D-5533F31A8E02

Q39471229-98BF5595-F7A8-4803-9678-5F8F482C746C

Q39471229-D01458C8-AC9A-418B-AAA6-A5C077677E14

Q39471229-EB1FE070-34BE-4F5F-A595-58357DABAC98

P2860

Q39471229-35D6ED33-CE09-4EF8-91CF-16A4D10BB171

Q39471229-67031D99-3466-427E-9961-7A0E32DCE33F

Q39471229-B4804E27-78CC-42B9-933D-01BA6B361517

Q39471229-C27E0F13-47D3-48E5-8121-8ED6553B50F6

Q39471229-CF686DA7-B6F5-4BCC-BCE9-62D5E991CC75

Q39471229-EF4AAE19-FF79-4DB4-943D-87A6BA3E205F

Q39471229-FEDB751A-FCF7-4068-8672-840458AA4D40

P304

Q39471229-C756D8C7-66CF-45E7-9AA7-3A423F878DA0

P31

Q39471229-5A74A871-2A63-43B0-AC9D-1C8E067304C0

P356

Q39471229-37836E66-A247-46B1-AD35-01ADA49F4F24

P407

Q39471229-21CE0AEA-68B9-4269-B055-C9EC606B2FAD

P433

Q39471229-285EB842-0410-4954-9A4E-41C1DD5E4ACF

P478

Q39471229-48E600CF-8621-4C0B-B3EA-4C5978690504

P50

Q39471229-A1D53F23-EEB0-4221-A840-5BA7E4DD330F

P577

Q39471229-FE621F06-2843-4B3A-818B-22FA4BDCD911

P5875

Q39471229-03C172A1-8B8F-4262-A65A-CD6E33474D18

P698

Q39471229-1A0B09EA-F788-4D94-948F-66DD5AFDAFF4

P356

P1433

Clinical Infectious Diseases

P1476

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis

@en

P2093

Aleida Verduguez

http://www.w3.org/2001/XMLSchema#string

Darsi Villarroel

http://www.w3.org/2001/XMLSchema#string

Ernesto Rojas

http://www.w3.org/2001/XMLSchema#string

Isidoro Alavi

http://www.w3.org/2001/XMLSchema#string

Jonathan Berman

http://www.w3.org/2001/XMLSchema#string

Julia Toledo

http://www.w3.org/2001/XMLSchema#string

Lineth Gracia

http://www.w3.org/2001/XMLSchema#string

Maria Maldonado

http://www.w3.org/2001/XMLSchema#string

Mary Cruz

http://www.w3.org/2001/XMLSchema#string

Miguel Guzman

http://www.w3.org/2001/XMLSchema#string

P2860

Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study

Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis

Advances in leishmaniasis

Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis.

Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes.

Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.

Miltefosine for new world cutaneous leishmaniasis.

P304

1255-1260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIT049

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235416462

http://www.w3.org/2001/XMLSchema#string

P698

23390069

http://www.w3.org/2001/XMLSchema#string